As January 2017, I am a Program Director for Pulmonary Fibrosis, Sarcoidosis, and other rare lung diseases at NHLBI. I oversee several clinical research protocols for phase I, Phase II and Phase III trials. Work with DSMB, DCC and CCC investigators and evaluate their reports as well as resolve complex problems of clinical trials or observational studies. I implement essential partnership with patients’ foundations and scientists in the field of rare lung diseases to facilitate clinical and human subjects’ research. Additionally, I authored several funding initiatives for Heart, Blood and sleep disorders (HLBS) research as well as COVID 19 research. Since June 2020, I serve as a Project Manager for the NIH’s Rapid Acceleration of Diagnostics (RADx) Tech initiative, a dedicated Congressional appropriation to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. My expertise in study design and analysis, and validation of emerging technologies enabled me to be incorporated into RADx Tech team and I provided critical management for about $ 50 Million contract projects in fight against COVID-19. I earnt two NIH Director’s (Dr. Francis Collins) awards in 2021 and received HHS Secretary’s (Mr. Xavier Becerra) award for distinguished services in May 2022. I obtained MD degree at Karl Franzens University, Graz, Austria and had extensive clinical work experience at University Hospital in Graz, where I did my medical residency. Later I successfully obtained Educational Commission for Foreign Medical Graduates (ECFMG) certification in United States and obtained training in pulmonary medicine at UPMC as observer fellow. Further, I achieved multi-disciplinary MPH and PhD degree in clinical and transitional sciences at University of Pittsburgh and accomplished postdoctoral fellowship at Simmons’s center for interstitial lung diseases at UPMC under the mentorship of Professor Dr. Naftali Kaminski. As an NIH funded investigator with expertise in genomic and proteomic of chronic lung diseases, I was employed as an assistant professor of medicine at Division of Pulmonary, Allergy, and Critical Care Medicine. I am expert in genomic, proteomic of chronic lung diseases, wide-ranging proficiency in clinical, biomedical, epidemiological, statistical methods, and translational sciences. Contributions to Science are found in the complete list of published works in the link.http://www.ncbi.nlm.nih.gov/pubmed/term=Vuga%20LJ%5BAuthor%5D&cauthor=true&cauthor_uid=24628285